Direct-acting antiviral agents (DAAs)

Direct-acting antiviral agents (DAAs) are medications used to treat hepatitis C by directly targeting the virus's ability to replicate. They work by blocking specific proteins vital for the virus’s life cycle, which helps prevent the virus from multiplying and damaging the liver. DAAs are highly effective, often curing the infection in just a few months, with fewer side effects compared to older treatments. Their precision makes them a cornerstone in modern hepatitis C management, significantly improving outcomes and reducing the risk of long-term liver complications.